OR WAIT null SECS
June 19, 2019
Catalent will manufacture products for Bristol-Myers Squibb while adding sterile biologics fill/finish and oral solids manufacturing and packaging capacity.
June 17, 2019
The US Federal Trade Commission (FTC) has requested additional information from Roche and Spark Therapeutics regarding Roche’s pending $4.3-billion acquisition of Spark.
Pfizer’s acquisition of Array BioPharma expands the company’s pipeline of investigational cancer therapies.
June 14, 2019
GSK has revealed that it has entered into a five-year collaboration with the University of California to advance genomic research and improve drug discovery.
A groundbreaking ceremony was held in Rahway, NJ for Merck’s new FLEx facility that incorporates G-CON’s prefabricated cleanroom units.
June 13, 2019
The acquisition will boost Merck’s pipeline for cancer, fibrosis, and autoimmune disease therapeutics.
In this collaboration, AbCellera will apply its expertise to generate panels of antibody candidates for Gilead to evaluate.
June 07, 2019
The current president of Novartis’ Advanced Accelerator Applications has been appointed as the new Novartis Pharmaceuticals president.
The acquisition will boost Biogen’s gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.
Paul Hudson, formerly CEO of Novartis Pharmaceuticals, has been tapped to succeed Olivier Brandicourt as CEO of Sanofi.